INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Open-Label Study Assessing Relative And Absolute Bioavailability
Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.
-
Accelerate Drug Development With Master Protocols
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Creating Operational Efficiency And Competitive Edge
Site networks offer a strategic approach to oncology clinical trials by accelerating study startup and expanding access to diverse patient populations.
-
Who Is Responsible When AI Helps Write The Consent Form?
AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.
-
Automatically Triggered Micropayments And Built-In Reporting8/5/2026
Automated micropayments and unified trial data ease site burdens, boost participant retention, and deliver real-time insights. Discover a better way to run clinical trials.
-
Partnering For Functional Solutions8/1/2025
We know that functional outsourcing is vital to clinical development today. This is why we build relationships and communicate with you to develop effective solutions.
-
Finding The Right CRO Partner For Early-Stage Oncology Trials11/21/2025
Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
-
Bringing Clinical Trials To Everyone's Backyard1/10/2025
Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.
-
Central eSource: Leveraging Site Technology2/27/2025
In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Niche CRO with a difference
Worldwide Clinical Trials Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
-
Harnessing decades of global drug product development and commercialization, you can rely on PCI's integrated speed solutions to simplify the supply chain.
-
Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
-
Rave Site Payments is a unified, cloud-based technology that makes site payments as easy as payroll. Your accounting department doesn’t skip paychecks or miscalculate wages and taxes, and now your clinical finance team doesn’t have to either.
-
Plan face-to-face, virtual, and hybrid life sciences events with precision using an end-to-end service that plans everything from investigator meetings to advisory boards and incentive trips.